| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.4M | -56.3% |
| SG&A Expense | $4.2M | -23.5% |
| Operating Income | -$10.2M | +40.6% |
| Pre-tax Income | -$23.4M | -484.0% |
| Net Income | -$23.4M | -484.0% |
| EPS (Basic) | -$11.15 | -109.2% |
| EPS (Diluted) | -$11.15 | -109.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $173K | -93.5% |
| Short-term Investments | $8.3M | +272.2% |
| Current Assets | $9.4M | +61.8% |
| Total Assets | $21.4M | +19.9% |
| Current Liabilities | $6.7M | +34.3% |
| Total Liabilities | $6.7M | +31.7% |
| Stockholders' Equity | $9.8M | -20.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.0M | +30.8% |
| Investing Cash Flow | -$6.1M | -430.6% |
| Financing Cash Flow | $12.6M | -3.8% |